Detalhe da pesquisa
1.
Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.
Qual Life Res
; 2024 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38879861
2.
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
BMC Cancer
; 22(1): 147, 2022 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123422
3.
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
Eur J Haematol
; 108(1): 34-44, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536308
4.
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry.
Br J Haematol
; 193(1): 119-124, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515050
5.
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
Hematol Oncol
; 39(4): 521-528, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342035
6.
Use of bisphosphonates in multiple myeloma patients in Denmark, 2005-2015.
Support Care Cancer
; 29(8): 4501-4511, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33458807
7.
Strategies to improve patient-reported outcome completion rates in longitudinal studies.
Qual Life Res
; 29(2): 335-346, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31549365
8.
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.
Am J Hematol
; 97(3): E117-E120, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967035
9.
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
Eur J Haematol
; 97(3): 303-9, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26710662
10.
The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.
EJHaem
; 4(4): 1006-1012, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38024635
11.
Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry.
Am J Hematol
; 92(10): E611-E614, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28707398
12.
The real-world outcomes of multiple myeloma patients treated with daratumumab.
PLoS One
; 16(10): e0258487, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644367
13.
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.
Am J Hematol
; 90(4): E73-4, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25561348
14.
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.
Front Immunol
; 11: 595035, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33240282
15.
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
Blood Cancer J
; 14(1): 65, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622134
16.
Potential value of pre-planned imaging of bone disease in multiple myeloma.
Blood Cancer J
; 13(1): 105, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419876
17.
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
Cancer Med
; 6(7): 1807-1816, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28639741
18.
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
PLoS One
; 12(12): e0188988, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29216227
19.
The Danish National Multiple Myeloma Registry.
Clin Epidemiol
; 8: 583-587, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27822103
20.
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.
Blood Cancer J
; 11(4): 70, 2021 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828079